BeSlim

Consultation

Every BeSlim journey at Face Medical begins with an in-depth consultation with one of our trained medical practitioners. This private, one-to-one appointment is crucial in assessing your current health status, weight history, lifestyle factors, and your goals for weight loss. During the consultation, we will evaluate your body mass index (BMI), check for any contraindications or health conditions, and determine your suitability for Mounjaro. You’ll receive a full medical history review and a clear explanation of how the treatment works, potential outcomes, and what to expect at each stage. We’ll also take time to address any concerns or questions you may have, ensuring you feel fully informed and confident before starting. If Mounjaro is suitable for you, we’ll design a bespoke treatment programme, including dosage schedules and ongoing reviews. Our team will remain on hand throughout your journey, providing expert support, motivation, and adjustments where needed.

Weight Loss Consultation Form

For us to ensure BeSlim is an appropriate treatment for you, we have created the link below to our consultation form. If you complete the form, this will help us evaluate each patient’s individual needs and ensure this treatment is suited to you. Once we have received your completed form a member of the team will review and contact you as soon as possible.

Click Here To Complete The Consultation Form

Individual Treatment Programme

Face Medical’s BeSlim programme is carefully structured to ensure you receive the full benefit of Mounjaro injections, a medication designed to mimic two gut hormones (GLP-1 and GIP) that regulate hunger and insulin. Administered via a once-weekly injection, Mounjaro works by slowing gastric emptying and increasing feelings of fullness, making it easier to reduce calorie intake. Each injection is self-administered at home following our guidance, or can be administered in-clinic if preferred. Treatment plans are tailored to individual needs, typically lasting 12-16 weeks, with regular reviews and dose adjustments depending on progress. Most patients begin to notice appetite reduction and weight loss within the first month, with continued results over time. While Mounjaro is generally well tolerated, some patients may experience mild side effects such as nausea, constipation, diarrhoea, or reduced appetite, particularly during the first few weeks. These often settle as the body adjusts. It’s important to stay hydrated and follow any dietary recommendations given. BeSlim also incorporates nutritional advice, lifestyle support, and progress tracking to maintain motivation and maximise success. With clinical trials showing significant weight reduction, BeSlim is considered a safe and effective choice for patients seeking a medically managed path to better health. Our team at Face Medical is here to offer ongoing guidance and reassurance throughout your journey. With the right support and consistency, BeSlim can be a transformative step toward a healthier, more confident you.

Further Advice

Mounjaro (tirzepatide) is a prescription-only medication originally developed to help manage type 2 diabetes, due to its ability to regulate blood sugar and improve insulin sensitivity. More recently, it has gained recognition for its powerful weight loss benefits, making it a valuable treatment option for patients with obesity or weight-related health concerns. Mounjaro mimics two naturally occurring hormones (GLP-1 and GIP) that help control appetite, improve metabolism, and reduce food intake. It is recommended for individuals with a BMI of 30 or above, or a BMI of 27+ with associated conditions such as hypertension, sleep apnoea, or type 2 diabetes. Because Mounjaro affects key metabolic pathways, it must only be used under qualified medical supervision. It is not a cosmetic or quick-fix solution – it is a potent medical therapy requiring professional assessment, tailored dosing, and regular monitoring. At Face Medical, your safety and wellbeing are our priority throughout your BeSlim treatment journey.